Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Realty Income Corp (O) vs Repligen Corporation Common Stock (RGEN) Price & Performance

Realty Income CorpTrade
Repligen Corporation Common StockTrade

Price performance (Past 24H)

Key statistics

Realty Income Corp vs Repligen Corporation Common Stock — how do they compare? Realty Income Corp trades at $55.65 (market cap $52.03B), while Repligen Corporation Common Stock trades at $178.15 (market cap $11.14B). The key difference: Realty Income Corp is far larger — about 4.7× Repligen Corporation Common Stock's market cap, and Realty Income Corp pays a 5.92% dividend while Repligen Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Realty Income Corp for 128 Days and Repligen Corporation Common Stock for 0 Days on average.

ORGEN
Market Cap
$52.03B$11.14B
Volume
16,838,2131,259,263
Sector
Real EstateHealth
52-Week High
$67.56$194.57
52-Week Low
$53.35$102.87
Typical Hold Time
128 Days0 Days
Enterprise Value
$82.66B$11.02B
Dividend Yield
5.92%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Realty Income Corp

Realty Income (O) trades at $55.17, up 0.86% on the day, but remains in a bearish technical trend with recent earnings misses. The REIT maintains strong fundamentals with 92.56% gross margins and consistent dividend payments, though valuation metrics appear elevated with a P/E of 40.14. Recent news highlights the stock's sensitivity to rising Treasury yields, with the 10-year at 5.26% creating headwinds for REIT valuations.

The outlook remains cautious with analyst consensus at Buy (38%) but technical indicators bearish. Key opportunities include the 6% dividend yield and 136 consecutive dividend increases, while risks center on interest rate sensitivity and debt levels approaching 40% of assets. The $64.16 price target suggests 16% upside if fundamentals overcome rate pressures.

Repligen Corporation Common Stock

RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.

Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

O
68% Buy32% Sell
Avg holding period · 128 Days
RGEN
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Realty Income Corp

Realty Income owns roughly 11,400 properties, most of which are freestanding, single-tenant, triple-net-leased retail properties. Its properties are located in 49 states and Puerto Rico and are leased to 250 tenants from 47 industries. Recent acquisitions have added industrial, office, manufacturing, and distribution properties, which make up roughly 17% of revenue.

Read more on O →

About Repligen Corporation Common Stock

Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.

Read more on RGEN →